Off-Label Treatments As Potential Accelerators in the Search for the Ideal Antifungal Treatment Of Cryptococcosis

References

• Almeida F , RodriguesML , CoelhoC. The still underestimated problem of fungal diseases worldwide. Front. Microbiol.10, 214–216 (2019).
   PubMed Web of Science ®Google Scholar
• Gnat S , ŁagowskiD , NowakiewiczA , DylągM. A global view on fungal infections in humans and animals: infections caused by dimorphic fungi and dermatophytoses. J. Appl. Microbiol.131(6), 2688–2704 (2021).
   PubMed Web of Science ®Google Scholar
• Borba HHL , SteimbachLM , RiverosBSet al. Cost–effectiveness of amphotericin B formulations in the treatment of systemic fungal infections. Mycoses61(10), 754–763 (2018).
   PubMed Web of Science ®Google Scholar
• Wasilczuk K , KorzeniewskiK. Immunocompromised travellers. Int. Marit. Health68(4), 229–237
   PubMedGoogle Scholar
• Segrelles-Calvo G , deS Araújo GR , FrasesS. Systemic mycoses: a potential alert for complications in COVID-19 patients. Future Microbiol.15(14), 1405–1413 (2020).
   PubMed Web of Science ®Google Scholar
• WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group . Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA324(13), 1330–1341 (2020).
   PubMed Web of Science ®Google Scholar
• Sinha P , MatthayMA , CalfeeCS. Is a ‘cytokine storm’ relevant to COVID-19?JAMA Intern. Med.180(9), 1152 (2020).
   PubMed Web of Science ®Google Scholar
• Segrelles‐Calvo G , AraújoGRS , Llopis‐PastorEet al. Prevalence of opportunistic invasive aspergillosis in COVID‐19 patients with severe pneumonia. Mycoses64(2), 144–151 (2021).
   PubMed Web of Science ®Google Scholar
• Idnurm A , BahnY-S , NielsenK , LinX , FraserJA , HeitmanJ. Deciphering the model pathogenic fungus Cryptococcus neoformans. Nat. Rev. Microbiol.3(10), 753–764 (2005).
   PubMed Web of Science ®Google Scholar
• Chayakulkeeree M , PerfectJ. Cryptococcosis. Infectious Disease: Diagnosis and Treament of Human Mycoses. © Springer Nature Switzerland AG., 255–276 (2008).
   Google Scholar
• Tsiodras S , PapageorgiouS , MeletiadisJet al. Rhodotorula mucilaginosa associacted meningitis: a subacute entity with high mortality. Case report and review. Med. Mycol. Case Rep.6, 46–50 (2014).
   PubMedGoogle Scholar
• Reboli AC , ShorrAF , RotsteinCet al. Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome. BMC Infect. Dis.11(1), 261 (2011).
   PubMedGoogle Scholar
• Rajasingham R , SmithRM , ParkBJet al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect. Dis.17(8), 873–881 (2017).
   PubMed Web of Science ®Google Scholar
• Idnurm A , BahnY-S , NielsenK , LinX , FraserJA , HeitmanJ. Deciphering the model pathogenic fungus Cryptococcus neoformans. Nat. Rev. Microbiol.3(10), 753–764 (2005).
   PubMed Web of Science ®Google Scholar
• Krysan DJ . Toward improved anti-cryptococcal drugs: novel molecules and repurposed drugs. Fungal Genet. Biol.78, 93–98 (2015).
   PubMed Web of Science ®Google Scholar
• Micallef C , AliyuSH , SantosR , BrownNM , RosembertD , EnochDA. Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England. J. Antimicrob. Chemother.70(6), 1908–1911 (2015).
   PubMed Web of Science ®Google Scholar
• Sloan DJ , DedicoatMJ , LallooDG. Treatment of cryptococcal meningitis in resource limited settings. Curr. Opin. Infect. Dis.22(5), 455–463 (2009).
   PubMed Web of Science ®Google Scholar
• Chang Y-L , YuS-J , HeitmanJ , WellingtonM , ChenY-L. New facets of antifungal therapy. Virulence8(2), 222–236 (2017).
   PubMed Web of Science ®Google Scholar
• World Health Organization . Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva, Switzerland (2018).
   Google Scholar
• Oprea TI , MestresJ. Drug repurposing: far beyond new targets for old drugs. AAPS J.14(4), 759–763 (2012).
   PubMed Web of Science ®Google Scholar
• Ribeiro NQ , SantosAPN , EmídioECPet al. Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis. Int. J. Antimicrob. Agents54(3), 301–308 (2019).
   PubMed Web of Science ®Google Scholar
• Ribeiro N de Q , CostaMC , MagalhãesTFFet al. Atorvastatin as a promising anticryptococcal agent. Int. J. Antimicrob. Agents49(6), 695–702 (2017).
   PubMed Web of Science ®Google Scholar
• Zhai B , WuC , WangL , SachsMS , LinX. The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections. Antimicrob. Agents Chemother.56(7), 3758–3766 (2012).
   PubMed Web of Science ®Google Scholar
• Delattin N , debrucker K , VandammeKet al. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms. J. Antimicrob. Chemother.69(4), 1035–1044 (2014).
   PubMed Web of Science ®Google Scholar
• Butts A , KrysanDJ. Antifungal drug discovery: something old and something new. PLoS Pathog.8(9), e1002870 (2012).
   PubMed Web of Science ®Google Scholar
• Ogundeji AO , PohlCH , SebolaiOM. Repurposing of aspirin and ibuprofen as candidate anti-Cryptococcus drugs. Antimicrob. Agents Chemother.60(8), 4799–4808 (2016).
   PubMed Web of Science ®Google Scholar
• Ribeiro N de Q , CostaMC , MagalhãesTFFet al. Atorvastatin as a promising anticryptococcal agent. Int. J. Antimicrob. Agents49(6), 695–702 (2017).
   PubMed Web of Science ®Google Scholar
• Fuchs BB , RajaMuthiahR , SouzaACRet al. Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin. Future Med. Chem.8(2), 117–132 (2016).
   PubMed Web of Science ®Google Scholar
• Oliveira EAM , FerreiraGF , LangKL. Drug repositioning of benzimidazole anthelmintics in the treatment of cryptococcosis: a review. Med. Chem. Res.31(1), 26–39 (2022).
   Web of Science ®Google Scholar
• Joffe LS , SchneiderR , LopesWet al. The anti-helminthic compound mebendazole has multiple antifungal effects against Cryptococcus neoformans. Front. Microbiol.8, 535 (2017).
   PubMed Web of Science ®Google Scholar
• Magalhães TFF , CostaMC , HolandaRAet al. N-acetylcysteine reduces amphotericin B deoxycholate nephrotoxicity and improves the outcome of murine cryptococcosis. Med. Mycol.58(6), 835–844 (2020).
   PubMed Web of Science ®Google Scholar
• Ogundeji AO , PohlCH , SebolaiOM. The repurposing of anti-psychotic drugs, quetiapine and olanzapine, as anti-Cryptococcus drugs. Front. Microbiol.8, 815–826 (2017).
   PubMed Web of Science ®Google Scholar
• Brilhante RSN , CaetanoEP , de OliveiraJSet al. Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species. Braz. J. Infect. Dis.19(5), 459–465 (2015).
   PubMed Web of Science ®Google Scholar
• Hai TP , VanAD , NganNTTet al. The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans. Mycoses62(9), 818–825 (2019).
   PubMed Web of Science ®Google Scholar
• Ko H-T , HsuL-H , YangS-Y , ChenY-L. Repurposing the thrombopoietin receptor agonist eltrombopag as an anticryptococcal agent. Med. Mycol.58(4), 493–504 (2019).
   Web of Science ®Google Scholar
• Butts A , KoselnyK , Chabrier-RosellóYet al. Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo. mBio5(1), e00765–13 (2014).
   PubMed Web of Science ®Google Scholar
• Rollini MMM . Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl. Microbiol. Biotechnol.58(5), 555–564 (2002).
   PubMed Web of Science ®Google Scholar
• Hilal-DandanR, KnollmannB, BruntonL . Goodman and Gilman's the Pharmacological Basis of Therapeutics (13th Edition).McGraw Hill, NY, USA (2017).
   Google Scholar
• Manzoni M , RolliniM. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl. Microbiol. Biotechnol.58(5), 555–564 (2002).
   PubMed Web of Science ®Google Scholar
• Jia M , HuangW , LiL , XuZ , WuL. Statins reduce mortality after non-severe but not after severe pneumonia: a systematic review and meta-analysis. J. Pharm. Pharm. Sci.18(3), 286–302 (2015).
   PubMed Web of Science ®Google Scholar
• Thomsen RW , RiisA , KornumJB , ChristensenS , JohnsenSP , SørensenHT. Preadmission use of statins and outcomes after hospitalization with pneumonia population-based cohort study of 29,900 patients. Arch. Intern. Med.168(19), 2081–2087 (2008).
   PubMedGoogle Scholar
• Cruz MC , BartlettMS , EdlindTD. In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles. Antimicrob. Agents Chemother.38(2), 378–380 (1994).
   PubMed Web of Science ®Google Scholar
• Bai RY , StaedtkeV , WanjikuTet al. Brain penetration and efficacy of different mebendazole polymorphs in a mouse brain tumor model. Clin. Cancer Res.21(15), 3462–3470 (2015).
   PubMed Web of Science ®Google Scholar
• Cruz MC , EdlindT. β-Tubulin genes and the basis for benzimidazole sensitivity of the opportunistic fungus Cryptococcus neoformans. Microbiology (NY)143(6), 2003–2008 (1997).
   PubMedGoogle Scholar
• Palacio JR , MarkertUR , MartínezP. Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages. Inflamm. Res.60(7), 695–704 (2011).
   PubMed Web of Science ®Google Scholar
• Uraz S , TahanG , AytekinH , TahanV. N-acetylcysteine expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic acid-induced colitis in rats. Scand. J. Clin. Lab. Invest.73(1), 61–66 (2013).
   PubMed Web of Science ®Google Scholar
• Jones AL . Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review. J. Toxicol. Clin. Toxicol.36(4), 277–285 (1998).
   PubMed Web of Science ®Google Scholar
• Bachert C , HörmannK , MösgesRet al. An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy58(3), 176–191 (2003).
   PubMed Web of Science ®Google Scholar
• Casadevall A , CoelhoC , CorderoRJBet al. The capsule of Cryptococcus neoformans. Virulence10(1), 822–831 (2019).
   PubMed Web of Science ®Google Scholar
• Laniado-Laborín R , Cabrales-VargasMN. Amphotericin B: side effects and toxicity. Rev. Iberoam. Micol.26(4), 223–227 (2009).
   PubMed Web of Science ®Google Scholar
• Aberg-Wistedt A . The antidepressant effects of 5-HT uptake inhibitors. Br. J. Psychiatry155(Suppl. 8), 32–40 (1989).
   Google Scholar
• Young TJ , OliverGP , PrydeD , PerrosM , ParkinsonT. Antifungal activity of selective serotonin reuptake inhibitors attributed to non-specific cytotoxicity. J. Antimicrob. Chemother.51(4), 1045–1047 (2003).
   PubMed Web of Science ®Google Scholar
• Rainey MM , KorostyshevskyD , LeeS , PerlsteinEO. The antidepressant sertraline targets intracellular vesiculogenic membranes in yeast. Genetics185(4), 1221–1233 (2010).
   PubMed Web of Science ®Google Scholar
• Spitzer M , GriffithsE , BlakelyKMet al. Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole. Mol. Syst. Biol.7(499), 1–14 (2011).
   Google Scholar
• Nayak R , XuJ. Effects of sertraline hydrochloride and fluconazole combinations on Cryptococcus neoformans and Cryptococcus gattii. Mycology1(2), 99–105 (2010).
   Google Scholar
• Katende A , MbwanjiG , FainiDet al. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania. Mycoses62(12), 1127–1132 (2019).
   PubMed Web of Science ®Google Scholar
• Villanueva-Lozano H , Treviño-RangelR de J , GonzálezGMet al. Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience. Infection46(1), 25–30 (2018).
   PubMed Web of Science ®Google Scholar
• Rhein J , HupplerHullsiek K , TugumeLet al. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial. Lancet Infect. Dis.19(8), 843–851 (2019).
   PubMed Web of Science ®Google Scholar
• Dolan K , MontgomeryS , BuchheitB , DiDoneLet al. Antifungal activity of tamoxifen: in vitro and in vivo activities and mechanistic characterization. Antimicrob. Agents Chemother.53(8), 3337–3346 (2009).
   PubMed Web of Science ®Google Scholar
• Cheng G . Eltrombopag, a thrombopoietin-receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile. Ther. Adv. Hematol.3(3), 155–164 (2012).
   PubMedGoogle Scholar
• Dihazi H , KesslerR , EschrichK. High osmolarity glycerol (HOG) pathway-induced phosphorylation and activation of 6-phosphofructo-2-kinase are essential for glycerol accumulation and yeast cell proliferation under hyperosmotic stress. J. Biol. Chem.279(23), 23961–23968 (2004).
   PubMed Web of Science ®Google Scholar
• Silva-Abreu M , EspinozaL , Rodríguez-LagunasMet al. Human skin permeation studies with PPARγ agonist to improve its permeability and efficacy in inflammatory processes. Int. J. Mol. Sci.18(12), 2548 (2017).
   PubMed Web of Science ®Google Scholar
• Serghides L , McDonaldCR , LuZet al. PPARγ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria. PLoS Pathog.10(3), e1003980 (2014).
   PubMed Web of Science ®Google Scholar
• Daynes RA , JonesDC. Emerging roles of PPARs in inflammation and immunity. Nat. Rev. Immunol.2(10), 748–759 (2002).
   PubMed Web of Science ®Google Scholar
• Schlottfeldt S , FernandesM , MartinsM , FonsecaDet al. Prevention of amphotericin B nephrotoxicity through use of phytotherapeutic medication. Rev. Esc. Enferm. USP doi:10.1590/S0080-623420150000700011 (2015).
   PubMed Web of Science ®Google Scholar
• Gardner DM . Modern antipsychotic drugs: a critical overview. Can. Med. Assoc. J.172(13), 1703–1711 (2005).
   PubMed Web of Science ®Google Scholar
• Suarez-Almazor ME , SpoonerCH , BelseckE , SheaB. Auranofin versus placebo in rheumatoid arthritis. Cochrane Database Syst. Rev.1(2), CD002048–CD002077 (2000).
   Google Scholar